Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-21-153587
Filing Date
2021-12-27
Accepted
2021-12-27 16:31:28
Documents
1
Group Members
AH BIO FUND III, L.P.AH EQUITY PARTNERS BIO II, L.L.C.AH EQUITY PARTNERS BIO III, L.L.C.AH EQUITY PARTNERS LSV I, L.L.C.AH EQUITY PARTNERS LSV II, L.L.C.ANDREESSEN HOROWITZ LSV FUND I, L.P.ANDREESSEN HOROWITZ LSV FUND II, L.P.BENJAMIN HOROWITZMARC ANDREES

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2136333d1_sc13d.htm SC 13D 219549
  Complete submission text file 0001104659-21-153587.txt   221462
Mailing Address 2865 SAND HILL ROAD, SUITE 101 MENLO PARK CA 94025
Business Address 2865 SAND HILL ROAD, SUITE 101 MENLO PARK CA 94025 650-798-3900
AH Bio Fund II, L.P. (Filed by) CIK: 0001725721 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139 6173152266
EQRx, Inc. (Subject) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93138 | Film No.: 211520948
SIC: 2834 Pharmaceutical Preparations